Skip to main content
NIH funding notice PAR-16-111

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)

Closed on November 14, 2017.

Posted
February 23, 2016
Close date
November 14, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,354,392 in first-year total cost, median $589,762.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-X (J2)]2
  2. Special Emphasis Panel[ZCA1 RTRB-R (A1)]1
  3. Special Emphasis Panel[ZCA1 SRB-J (J3)]1

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. MAYO CLINIC ROCHESTER1
  3. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
  4. UNIVERSITY OF TX MD ANDERSON CAN CTR1
Competing awards under PAR-16-111 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Pre-Clinical Novel Radiosensitizer Evaluation Program for Brain Tumors1U01CA227954-01SARKARIA, JANN N.MAYO CLINIC ROCHESTER, MN$596,490ZCA1
2018High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers1U01CA220714-01A1BENES, CYRIL HENRIWILLERS, HENNINGMASSACHUSETTS GENERAL HOSPITAL, MA$583,189ZCA1
2017Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches1U01CA216468-01A1KRISHNAN, SUNILLIN, STEVEN HSESHENGUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$596,334ZCA1
2017Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response1U01CA216449-01LAWRENCE, THEODORE SUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$578,379ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-16-111: Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01) | ScienceDex | ConductScience